Skip to main content
Top

Cancer Causes & Control

Issue 9/2003

Content (10 Articles)

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study

Martyn Plummer, Rolando Herrero, Silvia Franceschi, Chris J.L.M. Meijer, Peter Snijders, F. Xavier Bosch, Silvia de Sanjosé, Nubia Muñoz

Methyl-group dietary intake and risk of breast cancer among African-American women: a case–control study by methylation status of the estrogen receptor alpha genes

Kangmin Zhu, Nancy E. Davidson, Sandra Hunter, Xiaowei Yang, Kathleen Payne-Wilks, Chanel L. Roland, Dawn Phillips, Christy Bentley, Min Dai, Scott M. Williams

Risk factors for anal cancer: results of a population-based case–control study

Hung-Fu Tseng, Hal Morgenstern, Thomas M. Mack, Ruth K. Peters

Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort

D. Michal Freedman, Alice Sigurdson, Michele Morin Doody, R. Sowmya Rao, Martha S. Linet

Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12

Brenda Y. Hernandez, Katharine McDuffie, Lynne R. Wilkens, Lori Kamemoto, Marc T. Goodman

A critical analysis of reasons for improved survival from invasive cutaneous melanoma

Colin Glen Luke, Brendon John Coventry, Erwin Joseph Foster-Smith, David Murray Roder

Family history and colorectal cancer: predictors of risk

M.L. Slattery, T.R. Levin, K. Ma, D. Goldgar, R. Holubkov, S. Edwards

Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study

Kokichi Arisawa, Tomotaka Sobue, Itsuro Yoshimi, Midori Soda, Satoshi Shirahama, Hiroshi Doi, Shigeru Katamine, Hiroshi Saito, Minoru Urata

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine